Immunic inc reports q3 loss per share of $0.82

Immunic, inc. reports third quarter 2019 financial results and highlights recent activity.q3 loss per share $0.82.cash and cash equivalents, as of september 30, 2019, of $30.5 million is expected to fund company's operations into q4 of 2020.

IMUX Ratings Summary

IMUX Quant Ranking